Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
[Treatment-induced neuropathy of diabetes in a 44-year-old woman]
There is strong evidence that improved blood glucose control in individuals with diabetes mellitus reduces the risk of complications and leads to better long-term health outcomes. However, a rapid reduction in blood glucose levels can also lead to microvascular complications. Treatment-induced neuropathy in diabetes (TIND) is a painful neuropathy that may occur following a rapid decrease in blood glucose in patients with previously poorly controlled diabetes. This case report describes a woman who developed burning pain and sleep disturbances after being diagnosed with type 1 diabetes and undergoing a rapid reduction in blood glucose levels. Further investigations revealed diabetes-induced small fiber neuropathy consistent with TIND. Some studies suggest limiting the rate of blood glucose to reduce the risk of TIND, although current evidence is insufficient to support general recommendations. In patients with established TIND, increasing glucose levels is not advised. Management is instead symptomatic, focusing on relief of neuropathic pain and addressing any autonomic involvement. The prognosis is generally favourable.
There is strong evidence that improved blood glucose control in individuals with diabetes mellitus reduces the risk of complications and leads to better long-term health outcomes. However, a rapid reduction in blood glucose levels can also lead to microvascular complications. Treatment-induced neuropathy in diabetes (TIND) is a painful neuropathy that may occur following a rapid decrease in blood glucose in patients with previously poorly controlled diabetes. This case report describes a woman who developed burning pain and sleep disturbances after being diagnosed with type 1 diabetes and undergoing a rapid reduction in blood glucose levels. Further investigations revealed diabetes-induced small fiber neuropathy consistent with TIND. Some studies suggest limiting the rate of blood glucose to reduce the risk of TIND, although current evidence is insufficient to support general recommendations. In patients with established TIND, increasing glucose levels is not advised. Management is instead symptomatic, focusing on relief of neuropathic pain and addressing any autonomic involvement. The prognosis is generally favourable.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:31Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
Published on: September 29, 2017
Related Concept Videos
Peripheral Artery Disease IV: Nursing Management
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...